Adjuvanted Flu Vaccines Get Booster: House Report Presses FDA On Approval
Executive Summary
House appropriators are pressing FDA to license adjuvanted seasonal influenza vaccines that have a proven safety record.
You may also be interested in...
Therapeutic Cancer Vaccines Can Use Adjuvants, FDA Says
But even though the agency’s final guidance on cancer vaccines adds a section on adjuvants, the additional data requirements that FDA will request remain relatively vague.
FDA's Medical Countermeasure Program Among Senate Funding Priorities
FDA should spend $19 million of an increase in non-user fee funding in fiscal 2012 on the agency’s medical countermeasures effort, the Senate Appropriations Committee recommends in the report that accompanies the Agriculture/FDA appropriations bill approved by the panel Sept 8.
FDA's Medical Countermeasure Program Among Senate Funding Priorities
FDA should spend $19 million of an increase in non-user fee funding in fiscal 2012 on the agency’s medical countermeasures effort, the Senate Appropriations Committee recommends in the report that accompanies the Agriculture/FDA appropriations bill approved by the panel Sept 8.